Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PBK_L1704 in moderate to severe acute pain after bunionectomy
NCT05509868Phase 3Completed
- Sponsor
- Pharmbio Korea Inc.
- Start
- Jul 2022
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of PBK_L1704 in acute pain, sponsored by Pharmbio Korea Inc.. Started Jul 2022; status: completed.
02
Drugs
PBK_L1704
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05509868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05509868.